| Literature DB >> 30537968 |
Cristian Bersezio1, Javier Martín1, Andrea Herrera1,2, Alessandro Loguercio3, Eduardo Fernández4,5.
Abstract
BACKGROUND: The aesthetic self-perception and psychosocial impact of whitening is poorly explored in the literature; it is even less clear whether the effect of whitening may influence the psychology or social relations of patients. Therefore, the aim of this trial is to evaluate the impact of an at-home whitening procedure on patients' quality of life. Also, this study's secondary objective is the adaptation and validation of the Spanish version of the OES questionnaire (OES-SP).Entities:
Keywords: OES; OHIP; PIDAQ; Quality of life; Whitening teeth
Mesh:
Substances:
Year: 2018 PMID: 30537968 PMCID: PMC6290526 DOI: 10.1186/s12903-018-0668-2
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
OHIP-Esthetics, PIDAQ and OES questionnaires
| OHIP-Esthetics Questionnaire | |
| Q1 Have you noticed a tooth which doesn’t look right?1 | |
| Q2 Have you felt that your appearance has been affected by problems with your teeth?1 | |
| Q3 Have you had sensitive teeth for example to heat or to cold food or drinks?2 | |
| Q4 Have you had painful areas in your mouth?2 | |
| Q5 Have you been self-conscious because of your teeth?3 | |
| Q6 Have you felt uncomfortable about the appearance of your teeth?3 | |
| Q7 Have you felt that your food is less tasty because of problems with your teeth?4 | |
| Q8 Have you avoided smiling because of problems with your teeth?4 | |
| Q9 Have you found it difficult to relax because of problems with your teeth?5 | |
| Q10 Have you been a bit embarrassed because of problems with your teeth?5 | |
| Q11 Have you been less tolerant of your spouse or family because of problems with your teeth?6 | |
| Q12 Have you had difficulties doing your usual job because of problems with your teeth?6 | |
| Q13 Have you been unable to enjoy the company of other people very much because of problems with your teeth?7 | |
| Q14 Have you felt that life in general was less satisfying because of problems with your teeth?7 | |
| PIDAQ Questionnaire | |
| Dental Self-Confidence | |
| 1. I am proud of my teeth. | |
| 2. I like to show my teeth when I smile. | |
| 3. I am pleased when I see my teeth in the mirror. | |
| 4. My teeth are attractive to others. | |
| 5. I am satisfied with the appearance of my teeth. | |
| 6. I find my tooth position to be very nice. | |
| Social Impact | |
| 7. I hold myself back when I smile so my teeth don’t show so much. | |
| 8. If I don’t know people well I am sometimes concerned what they might think about my teeth. | |
| 9. I’m afraid other people could make offensive remarks about my teeth. | |
| 10. I am somewhat inhibited in social contacts because of my teeth. | |
| 11. I sometimes catch myself holding my hand in front of my mouth to hide my teeth. | |
| 12. Sometimes I think people are staring at my teeth. | |
| 13. Remarks about my teeth irritate me even when they are meant jokingly. | |
| 14. I sometimes worry about what members of the opposite sex think about my teeth. | |
| Psychological Impact | |
| 15. I envy the nice teeth of other people. | |
| 16. I am somewhat distressed when I see other people’s teeth. | |
| 17. Sometimes I am somewhat unhappy about the appearance of my teeth. | |
| 18. I think most people I know have nicer teeth than I do. | |
| 19. I feel bad when I think about what my teeth look like. | |
| 20. I wish my teeth looked better. | |
| Aesthetic Concern | |
| 21. I don’t like to see my teeth in the mirror. | |
| 22. I don’t like to see my teeth in photographs. | |
| 23. I don’t like to see my teeth when I look at a video of myself. | |
| Orofacial Esthetic Scale OES | |
| How do you feel about the appearance of your face, your mouth, your teeth and your replacements (prostheses, crowns, bridges and implants)? | |
| 0 is ‘Very dissatisfied’ and 10 is ‘Very satisfied’ | |
| 1. Your facial appearance. | |
| Apariencia de su cara | |
| 2. Appearance of your facial profile | |
| Apariencia de su perfil | |
| 3. Your mouth’s appearance (smile, lips and visible teeth) | |
| Aspecto de su boca (sonrisa, labios y dientes visibles) | |
| 4. Appearance of your rows of teeth | |
| Aspecto de la arcada de sus dientes | |
| 5. Shape/form of your teeth | |
| Forma de sus dientes | |
| 6. Colour of your teeth | |
| Color de sus dientes | |
| 7. Your gum’s appearance | |
| Aspecto de sus encías | |
| 8. Overall, how do you feel about the appearance of your face, your mouth, and your teeth | |
| En general, ¿Cómo se siente sobre la apariencia de su rostro, su boca y dientes? | |
| 1–7: summary score 8: overall impression score |
On OHIP-Esthetics questionnaire numbers correspond to the dimensions (1 = Functional limitation, 2 = Physical pain, 3 = Psychological discomfort, 4 = Physical disability, 5 = Psychological disability, 6 = Social disability, 7 = Handicap). In italic translation to Spanish
Baseline features of the participants. SD = standard deviation
| Baseline features | |
|---|---|
| Age (years; means ± SD) | 28.8 ± 9.1 |
| Minimum age (years) | 19 |
| Maximum age (years) | 55 |
| Male (%) | 50 |
| Baseline SGU (mean ± SD) | 7.26 ± 1.7 |
| L (mean ± SD) | 84.4 ± 3.84 |
| a (mean ± SD) | −0.12 ± 0.63 |
| b (mean ± SD) | 22.00 ± 2.8 |
Color change in ΔSGU and ΔE in the different assessment points
| Assessment points | Color change | |
|---|---|---|
| ΔSGU | ΔE | |
| Baseline vs. 3-week bleaching | 2.7 ± 1.5 a | 6.4 ± 3.4 A |
| Baseline vs. 1-week after bleaching | 2.6 ± 1.6 a | 5.9 ± 1.9 A |
| Baseline vs. 1-month after bleaching | 2.4 ± 1.7 a | 5.9 ± 1.8 A |
Comparisons are valid only within columns. The same letter indicates statistically similar means (p > 0.05
Distribution of scores by dimension and for the total OHIP-14 (Oral Health Impact Profile in Spanish) expressed in mean and SD
| Baseline | 1-week post bleaching | 1-month post bleaching | Corrected item total correlation of sum | Cronbach Alpha’s if Item Deleted | |
|---|---|---|---|---|---|
| Functional Limitation | 5.6 ± 2.3 | 4.7 ± 1.7* | 4.3 ± 1.5* | 0.637 | 0.808 |
| Physical Pain | 4.5 ± 1.5 | 4.2 ± 1.2 | 4.1 ± 1.3* | 0.361 | 0.842 |
| Psychological Discomfort | 5.7 ± 1.7 | 5.3 ± 1.4* | 5.2 ± 1.5* | 0.427 | 0.836 |
| Physical Disability | 3.2 ± 1.3 | 2.8 ± 1.1* | 2.7 ± 1.0* | 0.732 | 0.792 |
| Psychological Disability | 3.7 ± 1.8 | 3.3 ± 1.5* | 2.8 ± 1.1* | 0.792 | 0.772 |
| Social Disability | 2.8 ± 1.4 | 2.6 ± 1.0 | 2.4 ± 0.7* | 0.604 | 0.810 |
| Handicap | 2.9 ± 1.4 | 2.5 ± 0.98* | 2.4 ± 0.8* | 0.677 | 0.801 |
|
| 28.4 ± 8.0 | 25.4 ± 6.2* | 23.9 ± 5.6* |
. * = p < 0.05 compared to baseline by Wilcoxon test. Cronbach’s Alpha: 0.833
Distribution of scores by dimension and for the total PIDAQ expressed in mean and SD
| Baseline | 1-week post bleaching | 1-month post bleaching | Corrected item total correlation of sum | Cronbach Alpha’s if Item Deleted | |
|---|---|---|---|---|---|
| Self Confidence | 18.7 ± 5.5 | 21.3 ± 6.1* | 22.1 ± 5.4* | −0.727 | 0.832 |
| Social Impact | 16.8 ± 7.5 | 15.5 ± 7.1* | 15.7 ± 8.7 | 0.571 | −2.543 |
| Psychological Impact | 16.0 ± 5.2 | 14.7 ± 5.6* | 14.1 ± 5.6* | 0.513 | −1.088 |
| Aesthetic Concern | 7.2 ± 4.1 | 5.8 ± 3.1* | 6.0 ± 3.1* | 0.546 | −0.627 |
| PIDAQ | 58.7 ± 11.1 | 57.2 ± 11.3 | 57.9 ± 12.7 |
* = p < 0.05 compared to baseline by Wilcoxon test. Cronbach’s Alpha: 0.757
Distribution of scores by dimension and for the total OES expressed in mean and SD
| Baseline | 1-week post bleaching | 1 month post bleaching | Corrected item total correlation of sum | Cronbach Alpha’s if Item Deleted | |
|---|---|---|---|---|---|
| Mouth | 26.6 ± 7.1 | 28.6 ± 6.6* | 29.6 ± 5.9* | 0.870 | 0.460 |
| Face | 14.7 ± 3.4 | 14.8 ± 3.3 | 15.1 ± 3.0 | 0.452 | 0.853 |
| Teeth | 11.7 ± 3.7 | 13.6 ± 3.9* | 14.4 ± 3.2* | 0.768 | 0.578 |
| OES | 53.0 ± 11.9 | 57.0 ± 11.9* | 59.1 ± 10.9* |
Cronbach’s Alpha: 0.772
. * = p ≤ 0.05 compared to baseline by Wilcoxon test
Internal Consistency of OES Sp by questions (Q).Cronbach’s Alpha in different times (Baseline = 0.883; one week = 0.944 and;one month = 0.918)
| Items | Media of the scale if the item is deleted | Variance of the scale if the item is deleted | Correlation item-total corrected | Cronbach’s Alpha if the item is deleted |
|---|---|---|---|---|
| BASELINE | ||||
| 8 | 45.52 | 120.605 | 0.524 | 0.880 |
| Q2 | 45.86 | 124.717 | 0.363 | 0.895 |
| Q3 | 46.38 | 102.485 | 0.827 | 0.849 |
| Q4 | 46.71 | 102.667 | 0.813 | 0.851 |
| Q5 | 46.36 | 109.814 | 0.729 | 0.861 |
| Q6 | 47.93 | 112.592 | 0.581 | 0.876 |
| Q7 | 46.31 | 112.358 | 0.582 | 0.876 |
| Q8 | 46.05 | 111.138 | 0.831 | 0.854 |
| ONE WEEK RECALL | ||||
| Q1 | 49.47 | 118.499 | .593 | .900 |
| Q2 | 49.74 | 123.353 | .395 | .916 |
| Q3 | 50.02 | 103.561 | .838 | .878 |
| Q4 | 50.24 | 98.958 | .867 | .875 |
| Q5 | 50.16 | 102.590 | .814 | .880 |
| Q6 | 50.29 | 108.527 | .707 | .891 |
| Q7 | 49.52 | 118.675 | .565 | .903 |
| Q8 | 49.69 | 112.393 | .805 | .885 |
| ONE MONTH RECALL | ||||
| Q1 | 52.09 | 84.483 | .708 | .910 |
| Q2 | 52.46 | 84.071 | .511 | .929 |
| Q3 | 52.43 | 76.940 | .888 | .894 |
| Q4 | 52.63 | 78.675 | .843 | .898 |
| Q5 | 52.59 | 79.628 | .750 | .906 |
| Q6 | 52.52 | 84.945 | .610 | .917 |
| Q7 | 52.34 | 81.283 | .737 | .907 |
| Q8 | 52.20 | 81.761 | .867 | .899 |
Responsiveness OES Sp. The scores of each question and the total score were compared between baseline and post treatment (*)
| Baseline | One week recall | |||
|---|---|---|---|---|
| Media (SD) | Media (SD) | Effect Size | ||
| Q 1 | 7.50 ± 1.76 | 7.55 ± 1.67 | 0.661 | 0.028 |
| Q 2 | 7.16 ± 1.92 | 7.28 ± 1.83 | 0.327 | 0.063 |
| Q 3 | 6.64 ± 2.19 | 7.00 ± 2.05 |
| 0.164 |
| Q 4 | 6.31 ± 2.21 | 6.78 ± 2.25 |
| 0.213 |
| Q 5 | 6.66 ± 1.98 | 6.86 ± 2.16 | 0.133 | 0.101 |
| Q 6 | 5.09 ± 2.16 | 6.72 ± 2.04 |
| 0.755 |
| Q 7 | 6.71 ± 2.18 | 7.50 ± 1.72 |
| 0.362 |
| Q 8 | 6.97 ± 1.71 | 7.33 ± 1.63 |
| 0.211 |
|
|
|
|
| 0.334 |
| Face | 14.66 ± 3.44 | 14.83 ± 3.27 | 0.551 | 0.049 |
| Mouth | 26.62 ± 7.07 | 28.60 ± 6.56 |
| 0.280 |
| Teeth | 11.74 ± 3.65 | 13.59 ± 3.87 |
| 0.507 |
(*) Wilcoxon test (p < 0.05)
The scores of each question and the total score were compared between baseline and post treatment (*)